Apparent diffusion coefficient of fibrosis and regenerative nodules in the cirrhotic liver at MRI

American Journal of Roentgenology

Volumn 194, Issue 6, 2010, Pages 1515-1522

  Mwangi, Irene ^a   Hanna, Robert F ^b   Kased, Norbert ^c   Malek, Peter ^d   Shiehmorteza, Masoud ^a   Wolfson, Tanya ^e   Gamst, Anthony ^e   Sirlin, Claude ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Medicine   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LAC USC MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apparent diffusion coefficient; Diffusion weighted imaging; Fibrosis; Liver; MRI

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; EX VIVO STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER NODULE; LIVER PARENCHYMA; LIVER REGENERATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; LIVER CELL CARCINOMA; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; REGRESSION ANALYSIS;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOBENIC ACID; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS;

EID: 77953249305     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.09.3484     Document Type: Article

References (45)

1. Wong HJ, Legnini MW, Whitmore HH. The diffusion of decision support systems in healthcare: are we there yet? J Healthc Manag 2000; 45:240-249; discussion, 249-253
2. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127:S5-S16
3. Berg T, Sarrazin C, Hinrichsen H, et al. Does noninvasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C? Hepatology 2004; 39:1456-1457; author reply, 1457-1458
4. Talwalkar JA. Shall we bury the sword? Imaging of hepatic fibrosis. Gastroenterology 2006; 131:1669-1671
5. Boulanger Y, Amara M, Lepanto L, et al. Diffusion-weighted MR imaging of the liver of hepatitis C patients. NMR Biomed 2003; 16:132-136
6. Kugelmas M. Liver biopsy. Am J Gastroenterol 2004; 99:1416-1417
7. Zhu JY, Leng XS, Dong N, Qi GY, Du RY. Measurement of liver volume and its clinical significance in cirrhotic portal hypertensive patients. World J Gastroenterol 1999; 5:525-526
8. Le Bihan D. Diffusion/perfusion MR imaging of the brain: from structure to function. Radiology 1990; 177:328-329
9. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988; 168:497-505
10. Le Bihan D, Turner R, Douek P, Patronas N. Diffusion MR imaging: clinical applications. AJR 1992; 159:591-599
11. Aube C, Racineux PX, Lebigot J, et al. Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging: preliminary results. J Radiol 2004; 85:301-306
12. Koinuma M, Ohashi I, Hanafusa K, Shibuya H. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 2005; 22:80-85
13. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003; 226:71-78
14. Kim T, Murakami T, Takahashi S, Hori M, Tsuda K, Nakamura H. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR 1999; 173:393-398
15. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR 1998; 170:397-402
16. Namimoto T, Yamashita Y, Sumi S, Tang Y, Takahashi M. Focal liver masses: characterization with diffusion-weighted echo-planar MR imaging. Radiology 1997; 204:739-744
17. Muller MF, Prasad P, Siewert B, Nissenbaum MA, Raptopoulos V, Edelman RR. Abdominal diffusion mapping with use of a whole-body echo-planar system. Radiology 1994; 190:475-478
18. Colagrande S, Carbone SF, Carusi LM, Cova M, Villari N. Magnetic resonance diffusion-weighted imaging: extraneurological applications. Radiol Med 2006; 111:392-419
19. Taouli B, Tolia AJ, Losada M, et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR 2007; 189:799-806
20. Girometti R, Furlan A, Bazzocchi M, et al. Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. Radiol Med 2007; 112:394-408
21. Lewin M, Poujol-Robert A, Boelle PY, et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 2007; 46:658-665
22. Taouli B, Chouli M, Martin AJ, Qayyum A, Coakley FV, Vilgrain V. Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging 2008; 28:89-95
23. Saygili OB, Tarhan NC, Yildirim T, Serin E, Ozer B, Agildere AM. Value of computed tomography and magnetic resonance imaging for assessing severity of liver cirrhosis secondary to viral hepatitis. Eur J Radiol 2005; 54:400-407
24. Ohtomo K, Baron RL, Dodd GD 3rd, et al. Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT. Radiology 1993; 188:31-35
25. Brancatelli G, Federle MP, Ambrosini R, et al. Cirrhosis: CT and MR imaging evaluation. Eur J Radiol 2007; 61:57-69
26. Matsuo M, Kanematsu M, Kondo H, et al. Confluent hepatic fibrosis in cirrhosis: ferumoxides-enhanced MR imaging findings. Abdom Imaging 2001; 26:146-148
27. Ohtomo K, Baron RL, Dodd GD 3rd, Federle MP, Ohtomo Y, Confer SR. Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging. Radiology 1993; 189:871-874
28. Yang DM, Kim HS, Cho SW. Pictorial review: various causes of hepatic capsular retraction: CT and MR findings. Br J Radiol 2002; 75:994-1002
29. Annet L, Peeters F, Abarca-Quinones J, Leclercq I, Moulin P, Van Beers BE. Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging 2007; 25:122-128
30. Van Beers BE, Materne R, Annet L, et al. Capillarization of the sinusoids in liver fibrosis: noninvasive assessment with contrast-enhanced MRI in the rabbit. Magn Reson Med 2003; 49:692-699
31. Moteki T, Horikoshi H, Oya N, Aoki J, Endo K. Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted reordered turbo-FLASH magnetic resonance images. J Magn Reson Imaging 2002; 15:564-572
32. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003; 229:409-414
33. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999; 210:617-623
34. Hollingsworth KG, Lomas DJ. Influence of perfusion on hepatic MR diffusion measurement. NMR Biomed 2006; 19:231-235
35. Szafer A, Zhong J, Gore JC. Theoretical model for water diffusion in tissues. Magn Reson Med 1995; 33:697-712
36. 19F NMR. Magn Reson Med 1998; 40:1-13
37. Huet PM, Pomier-Layrargues G, Villeneuve JP, Varin F, Viallet A. Intrahepatic circulation in liver disease. Semin Liver Dis 1986; 6:277-286
38. Nascimento C, Bottino A, Nogueira C, Pannain V. Analysis of morphological variables and arterialization in the differential diagnosis of hepatic nodules in explanted cirrhotic livers. Diagn Pathol 2007; 2:51
39. Onori P, Morini S, Franchitto A, Sferra R, Alvaro D, Gaudio E. Hepatic microvascular features in experimental cirrhosis: a structural and morphometrical study in CCl4-treated rats. J Hepatol 2000; 33:555-563
40. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991; 22:172-178
41. Vollmar B, Siegmund S, Menger MD. An intravital fluorescence microscopic study of hepatic microvascular and cellular derangements in developing cirrhosis in rats. Hepatology 1998; 27:1544-1553
42. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22:983-993
43. Guan S, Zhou KR, Zhao WD, Peng WJ, Tang F, Mao J. Magnetic resonance diffusion-weighted imaging in the diagnosis of diffuse liver diseases in rats. Chin Med J (Engl) 2005; 118:639-644
44. Kim T, Baron RL, Nalesnik MA. Infarcted regenerative nodules in cirrhosis: CT and MR imaging findings with pathologic correlation. AJR 2000; 175:1121-1125
45. Norris DG. The effects of microscopic tissue parameters on the diffusion weighted magnetic resonance imaging experiment. NMR Biomed 2001; 14:77-93